CME Group Inc. (CME) — Analyst outlook / Analyst consensus target is. Based on 35 analyst ratings, the consensus is bullish — 13 Buy, 17 Hold, 5 Sell.
The consensus price target is $311.83 (low: $300.00, high: $340.00), representing an upside of 5% from the current price $297.03.
Analysts estimate Earnings Per Share (EPS) of $10.19 and revenue of $6.11B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $9.69 vs est $10.19 (missed -4.9%). 2025: actual $11.18 vs est $11.17 (beat +0.1%). Analyst accuracy: 97%.
CME Stock — 12-Month Price Forecast
$311.83
▲ +4.98% Upside
Average Price Target
Based on 35 Wall Street analysts offering 12-month price targets for CME Group Inc., the average price target is $311.83, with a high forecast of $340.00, and a low forecast of $300.00.
The average price target represents a +4.98% change from the last price of $297.03.
Highest Price Target
$340.00
Average Price Target
$311.83
Lowest Price Target
$300.00
CME Analyst Ratings
Hold
Based on 35 analysts giving stock ratings to CME Group Inc. in the past 3 months
EPS Estimates — CME
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $9.69
vs Est $10.19
▼ 5.1% off
2025
Actual $11.18
vs Est $11.17
▲ 0.1% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Revenue Estimates — CME
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $6.130B
vs Est $6.114B
▲ 0.3% off
2025
Actual $6.521B
vs Est $6.519B
▲ 0.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
